Scandal-plagued Goldman Sachs has sunk deep into a bear market. One technical analyst says it could get worse.
Boeing is running into trouble this week and now faces a critical technical test, according to one technician.
For the investor fresh on the hunt for yield, strategist Matt Maley has some tips for the search (and three names to consider).
The banks got banged up this week. The steep sell-offs have one market watcher changing his mind on the sector.
In a wild week for the Dow, one corner of the index has proven immune to the worst of the volatility: health care. Dow stocks Pfizer, UnitedHealth and Merck remain within reach of 52-week highs.
Emerging markets are in the middle of a meltdown. One of the worst hit of the emerging markets could see the biggest rebound.
Advanced Micro Devices' hot streak hit a brick wall this week. One chart watcher says more weakness could present an opportunity.
FANG got wrecked this week. At least one of those names could have hit a bottom, according to Matt Maley, equity strategist at Miller Tabak.
Banks' weakness this year has them perched at a key critical level. The next move could determine whether it's a boom or bust, says market watcher.
Facebook has flashed a technical warning sign and it has one former bull worried.